Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Strong Sales Boost Beckman Coulter s Q1 Profit; R&D Static

NEW YORK, April 29 - Beckman Coulter today said first-quarter profit rose nearly 20 percent as sales improved for its robotic automation and genetic analysis tools.

Sales for the period ended March 31 climbed 3.2 percent to $446.7 million as sales increased in the Americas and Europe. Sales declined in Asia, however.

Net earnings were $28 million, or $.43 per share, compared with $23.4 million, or $.37 per share, one year ago, Beckman said.  

The company added that second-quarter sales will grow 6 percent.

R&D spending, meanwhile, was static year over year at about $42 million. However, Beckman's cash and cash equivalents as of March 31 were $35 million, off slightly from the $36 million it posted one year ago, the firm said.


For more information, readers may click here.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.